These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16546858)

  • 1. Efficacy of systemic therapy in advanced pancreatic carcinoma.
    Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
    Acta Oncol; 2006; 45(2):136-43. PubMed ID: 16546858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer: from molecular signature to target therapy.
    Longo R; Cacciamani F; Naso G; Gasparini G
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):197-211. PubMed ID: 18436450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern systemic therapy of advanced pancreatic cancer: impact on overall survival and medico economical aspects].
    Mazzuri S; Roth A
    Rev Med Suisse; 2005 Jun; 1(24):1616-20. PubMed ID: 16028707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of patients with gastric adenocarcinoma.
    Foukakis T; Lundell L; Gubanski M; Lind PA
    Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of antineoplastic chemotherapy of pancreatic cancer].
    Matthias M; Wolff H
    Zentralbl Chir; 1987; 112(21):1322-36. PubMed ID: 3324556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
    Asuthkar S; Rao JS; Gondi CS
    Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: standards for the 21st century.
    Archie V; Kauh J; Jones DV; Cruz V; Karpeh MS; Thomas CR
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):123-31. PubMed ID: 16412659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials referral resource. Current phase II and phase III clinical trials for pancreatic cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Jul; 18(8):1008, 1013-4, 1016. PubMed ID: 15328895
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment for pancreatic cancer: current therapy and continued progress.
    Lockhart AC; Rothenberg ML; Berlin JD
    Gastroenterology; 2005 May; 128(6):1642-54. PubMed ID: 15887156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medical management of pancreatic cancer: a review.
    McKenna S; Eatock M
    Oncologist; 2003; 8(2):149-60. PubMed ID: 12697940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in Systemic Therapy for Pancreatic Cancer.
    Brown TJ; Reiss KA; O'Hara MH
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e397082. PubMed ID: 37192430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer in young adults: changes, challenges, and solutions.
    Primavesi F; Stättner S; Schlick K; Kiesslich T; Mayr C; Klieser E; Urbas R; Neureiter D
    Onco Targets Ther; 2019; 12():3387-3400. PubMed ID: 31118690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
    Yu WD; Ma Y; Flynn G; Muindi JR; Kong RX; Trump DL; Johnson CS
    Cell Cycle; 2010 Aug; 9(15):3022-9. PubMed ID: 20699664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: covalent modification.
    Lohman GJ; Stubbe J
    Biochemistry; 2010 Feb; 49(7):1404-17. PubMed ID: 20088569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.